Bayer Completes Perfuse Therapeutics Acquisition for PER-001 | Lucid Diligence Brief
Bayer has closed its acquisition of Perfuse Therapeutics, securing full rights…
Merck and Protillion Biosciences Collaboration Examined | Lucid Diligence Brief
Merck and Protillion partner on AI protein design. Assess milestones, platform…
Oncology Today—June 2, 2026
This week’s Oncology update highlights precision-oncology momentum across…
Women’s Health Today—May 27, 2026
This biweekly Women’s Health video recap highlights regulatory progress,…
Oncology Today—May 25, 2026
This week’s Oncology update highlights regulatory progress, biomarker-driven…
Oncology Today—May 18, 2026
This week’s Oncology update highlights regulatory approvals, breakthrough…
Cell and Gene Therapy Today—May 14, 2026
This week’s Gene and Cell Therapy update highlights regulatory updates,…
AI in Healthcare and Digital Health Today—April 28, 2026
This week’s Artificial Intelligence and Digital Health update highlights…
Oncology Today—April 27, 2026
This week’s Oncology update highlights regulatory approvals, late-stage trial…
Respiratory Today—April 24, 2026
This week’s Respiratory Research update highlights regulatory approvals,…